BFC Planning’s PAVmed PAVM Stock Holding History
Bought
Maintained
Sold
Other funds holding PAVM
BFC Planning's PAVM Position: Q3 2026 in Review
BFC Planning held its PAVmed (PAVM) position steady in Q3 2026 at 2 shares worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #3454.
BFC Planning first reported a position in PAVM in Q2 2026 and has held it in 2 quarters since. The position peaked at $12 in Q2 2026. 17 funds tracked by Wall St. Rank hold PAVM as of Q3 2026.
- BFC Planning held 2 shares of PAVmed worth $7 as of Q3 2026.
- BFC Planning left its PAVmed share count unchanged in Q3 2026.
- PAVmed made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3454 holding.
- BFC Planning first reported a position in PAVmed in Q2 2026 and has held it in 2 quarters since.
- BFC Planning's PAVmed position peaked at $12 in Q2 2026.
- 17 funds tracked by Wall St. Rank held PAVmed as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.